Board of Trustees

Dr. Markus Baumanns

Dr. Markus Baumanns is Executive Partner of business consultants company companions in Hamburg and of the investment company s&b impact invest, which operates in Germany and Colombia. company companions support businesses and organisations engaged in change projects of strategic importance. Since the beginning of his professional career, Dr. Markus Baumanns has dealt with the managing, establishing and directing non-profit enterprises. He has been head of division at the Press and Information Office of the Federal Government, a German Diplomat of the Foreign Office, also in South America, and set up an international elite university in Hamburg, Bucerius Law School, acting as managing director. Furthermore, he was a member of the ZEIT Foundation Ebelin and Gerd Bucerius Board for three years.

Markus Baumanns holds a doctorate in history, having studied and earned his doctoral degree in Cologne, Oxford and Vienna. He is a Supervisory Board member of three globally operating medium-sized enterprises and a board and presidium member of two foundations promoting science and entrepreneurship. He is a much sought-after speaker on leadership and change issues, a columnist for the “Handelsblatt” and co-author of the recently published book “Kein Bullshit. Was Manager heute wirklich können müssen” (Murmann Verlag, 2014).

Prof. Detlev Ganten

Professor Detlev Ganten, born in Lüneburg in 1941, studied medicine in Würzburg, Montpellier (France) and Tübingen and did several years of research at McGill University in Montreal (Canada), where he earned his Doctor of Philosophy (Ph.D.). In 1975, Detlev Ganten accepted a call to the Pharmacological Institute of the University of Heidelberg. In 1991, Professor Ganten became Founding and Managing Director of the Max Delbrück Center of Molecular Medicine (MDC) Berlin-Buch and Full Professor of Clinical Pharmacology at the Benjamin Franklin Clinic of Freie Universität Berlin. From 2004 to 2008, Professor Ganten was Executive Board Chairman of Charité - Universitätsmedizin Berlin, which was created as a merger of Freie Universität Berlin and Humboldt University Berlin. Since 2005, Professor Ganten has been Chairman of the Board of Trustees of the Stiftung Charité. In addition, since 2009, he has been Chairman of the Joint Board of Trustees of the Max Planck Institute of Colloids and Interfaces (MPI-KG) and the Max Planck Institute of Molecular Plant Physiology (MPI-MP), as well as President of the World Health Summit.

Prof. Dr. Karl Max Einhäupl

Neurologist, born in Munich in 1947. Studied human medicine at Ludwig Maximilians University in Munich. Was appointed Professor at the Neurological Clinic of LMU Munich with “Neurological Intensive Care Medicine” as a specialty in 1988. Was Director of the Charité Berlin Clinic for Neurology from 1993 to 2008, and from 2007 to 2008 Director of Charité Centrum CC15 for Neurology, Neurosurgery and Psychiatrics. Has been Executive Board Chairman of Charité - Universitätsmedizin Berlin since 2008.

Was awarded the Order of Merit of the Federal Republic of Germany in 2004. Was member of the German Council of Science and Humanities from 1998 to 2006, and from 2001 to 2006 Chairman of the German Council of Science and Humanities. Has been Chairman of the Foundation Council of the Stiftung Deutsche Schlaganfallhilfe since 2002 and, since 2005, member of the Deutsche Akademie der Naturforscher Leopoldina (German National Academy of Sciences). Member of the Otto-von-Guericke-Universität Magdeburg’s Board of Trustees since 2007. Chairman of the TU Munich University Council since 2007. Chairman of the Programme Council of the “Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz” (LOEWE) of Hesse’s Ministry of Science and Art since 2007.

Astrid Lurati

Astrid Lurati, born in Minden in 1966, has served as Hospital Director and member of the Executive Board of the Charité – Universitätsmedizin Berlin since the 15th May 2016.  In this position, she is particularly responsible for the advancement of patient care within the overall strategic development of the Charité.

Mrs. Lurati studied Business Economics at the University of Hamburg, qualifying in 1994 with a degree in Business Administration. Following this, in 1998 she received a Master of Pharmaceutical Medicine from the University of Witten/Herdecke.

Mrs. Lurati’s professional career began in 1986 in Hamburg where she embarked on an apprenticeship in Hotel Business Management at the “Vier Jahreszeiten” Hotel. On completion of this training, Mrs. Lurati was employed for some time within the banking sector, where she worked in the Department of Corporate Finance und Equity Research advising the chemical and pharmaceutical industry. From 1997, she was employed at the Bayer AG, Leverkusen where she headed the Department of Strategic Planning, later moving to the Department of Investor Relations. In 2003, Mrs. Lurati returned to Hamburg where she would spend the next thirteen years of her professional career working at the University Medical Center Hamburg-Eppendorf (UKE). This phase of her professional life began with a year as Department Business Director following which she was swiftly promoted to the position of Head of Hospital Financing. Subsequently in 2007, she became Deputy Commercial Director of the UKE. During this period, she also served intermittently as Acting Commercial Director.

Mrs. Lurati is a founding member of „Hamburg macht Kinder gesund“, an association that provides financial assistance for seriously ill children whose medical treatment is not covered by standard health insurance. She is also an Executive Board member of “Stiftung für Gesundheit und Hochbegabung”, a foundation that supports intellectually gifted individuals. In addition, she is a member of the Economic Board of the Christian Democratic Party (CDU) and for an interim period, she served as a member of the CDU Executive Board in Hamburg.

Mrs. Lurati is married with three daughters.

Prof. Dr. Brigitte Oetker

• 1984 – 1990: Managing Director of the Association of Arts and Culture of the German Economy, reg. Ass., at the Federation of German Industries
• since 1988: Member of the Villa Romana, reg. Ass., Board, Florence
• since 1989: Editor of the Jahresring – Jahrbuch für moderne Kunst
• 1994 – 1997: Curator for Kunst in der Leipziger Messe with Mechthild von Dannenberg and Christiane Maria Schneider
• 1998: Curator for MAI 98 at the Josef Haubrich Art Hall Cologne (exhibition on contemporary art) together with Christiane Maria Schneider
• Since 2004: Vice-president of the Bundesverband der Fördervereine Deutscher Museen für bildende Kunst e.V.
• 2008: Curator for the exhibition Gedichte der Zukunft Gallery of Contemporary Art, Leipzig
• Since 2007: Member of the Board of Trustees of Stiftung Charité
• Since 2010: Member of the Board of Trustees of Freunde der Berliner Philharmoniker e.V.
• Since 2013: Chairperson of ifa Freunde des Deutschen Pavillons / Biennale Venedig e.V.

Prof. Dr. Axel R. Pries

• 1979 Medical examination, University of Cologne
• 2/1980 Doctoral degree (Dr. med., summa cum laude)
• 1980 Postdoctoral Fellow, University of Cologne
• 1985 Research Assistant (C1), Dept. of Physiology, FU
• 7/1990 Habilitation, Medical Faculty, Freie Universität Berlin (FU)
• 1991 Lecturer of Physiology (C2), Dept. of Physiology, FU
• 1995 Associate Professor, Dept. of Physiology, FU
• 1997-1998 Senior Physician, Institute of Anaesthesiology,
• German Heart Centre Berlin, DHZB
• 12/1998 Full Professor, Dept. of Physiology, FU
• Since 2001 Head, Institute of Physiology, Charité-Berlin
• 2003-2015 Board Member, Faculty of Medicine, Charité-Berlin
• 2008-2015 Vice Director, Centre for Preclinical Medicine, Charité-Berlin
• 2009-2013 Vice Director, Centre for Cardiovascular Research, CCR, Charité-Berlin
• Since 2011-2012 Chair, ‘Lehre Board’, Charité-Berlin
• Since 2014 Chair, ‘Studienausschuss Modellstudiengang Medizin’

Prof. Dr. Jens Schneider-Mergener

Jens Schneider-Mergener studied chemistry and biochemistry at the Universities of Bielefeld and Munich. He earned a doctorate at LMU Munich in the field of biochemistry and subsequently worked at the California Institute of Technology in Pasadena, in the field of AIDS research. There, he discovered the HIV-1 Protease, which served as the basis for the development of anti-HIV-1 agents. From there, before reunification, he switched to the Charité, where he headed a research group that focused on the development of biochips for a faster identification of medicaments. In 1994, he founded the technology enterprise Jerini AG, whose management he assumed in 2000 and which he transformed into a pharmaceutical company. After the stock market launch of Jerini AG in 2005 and the successful development and market launch of the first bradycinine antagonists against the Hereditary Angio-oedema, he sold the company to Shire Pharmaceuticals in 2008. Together with his wife, he then founded the non-profit Kusala Foundation, which supports projects dedicated to the topic of spirit and health. Furthermore, he did four years of training in Gestalt psychotherapy. Since 1989, Jens Schneider-Mergener has been studying the theory and practice of Vipassana Meditation. Today, he is Chairman of the Management Board of Adrenomed AG.